Nuvation Bio Inc.
Company Stats
- Market Cap
- $2.0B
- as of Sep 30, 2026
- Shares Outstanding
- 351.1M
- Free Float
- 40.5%
Income Statement
- Revenue
- $62.9M
- Operating Income
- -$213.1M
- Net Income
- -$204.6M
- EBITDA
- -$211.3M
Balance Sheet
- Cash & Equivalents
- $164.1M
Returns & Capital
- SBC, 3Y Avg
- $29.2M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $62.9M | — | — |
| FY2024 | $7.9M | — | — |
| FY2023 | $0 | — | — |
Annual filing data through FY ended December 31, 2025; shares and float as of October 14, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back